Literature DB >> 24533679

Comments on 'low serum sex hormone binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients'.

Christina Wang1, Ronald S Swerdloff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24533679      PMCID： PMC4174595          DOI： 10.1111/cen.12430

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  20 in total

1.  A critical evaluation of simple methods for the estimation of free testosterone in serum.

Authors:  A Vermeulen; L Verdonck; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic.

Authors:  G Corona; E Mannucci; L Petrone; V Ricca; G Balercia; R Mansani; V Chiarini; R Giommi; G Forti; M Maggi
Journal:  Int J Impot Res       Date:  2006 Mar-Apr       Impact factor: 2.896

3.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

4.  Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats.

Authors:  L Nikolaenko; Y Jia; C Wang; M Diaz-Arjonilla; J K Yee; S W French; P Y Liu; S Laurel; C Chong; K Lee; Y Lue; W N P Lee; R S Swerdloff
Journal:  Endocrinology       Date:  2013-11-26       Impact factor: 4.736

5.  Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

Authors:  David E Laaksonen; Leo Niskanen; Kari Punnonen; Kristiina Nyyssönen; Tomi-Pekka Tuomainen; Veli-Pekka Valkonen; Riitta Salonen; Jukka T Salonen
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

6.  The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.

Authors:  Rita Rastogi Kalyani; Manuel Franco; Adrian S Dobs; Pamela Ouyang; Dhananjay Vaidya; Alain Bertoni; Susan M Gapstur; Sherita Hill Golden
Journal:  J Clin Endocrinol Metab       Date:  2009-09-29       Impact factor: 5.958

7.  Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor.

Authors:  Hung-Yun Lin; I-Chen Yu; Ruey-Shen Wang; Yei-Tsung Chen; Ning-Chun Liu; Saleh Altuwaijri; Cheng-Lung Hsu; Wen-Lung Ma; Jenny Jokinen; Janet D Sparks; Shuyuan Yeh; Chawnshang Chang
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

8.  Sex hormone-binding globulin and risk of type 2 diabetes in women and men.

Authors:  Eric L Ding; Yiqing Song; JoAnn E Manson; David J Hunter; Cathy C Lee; Nader Rifai; Julie E Buring; J Michael Gaziano; Simin Liu
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245

9.  Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients.

Authors:  Xiaomin Hua; Yanjun Sun; Yingjie Zhong; Wenhuan Feng; Hong Huang; Weimin Wang; Tianyan Zhang; Yun Hu
Journal:  Clin Endocrinol (Oxf)       Date:  2013-12-05       Impact factor: 3.478

10.  Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.

Authors:  John R B Perry; Michael N Weedon; Claudia Langenberg; Anne U Jackson; Valeriya Lyssenko; Thomas Sparsø; Gudmar Thorleifsson; Harald Grallert; Luigi Ferrucci; Marcello Maggio; Giuseppe Paolisso; Mark Walker; Colin N A Palmer; Felicity Payne; Elizabeth Young; Christian Herder; Narisu Narisu; Mario A Morken; Lori L Bonnycastle; Katharine R Owen; Beverley Shields; Beatrice Knight; Amanda Bennett; Christopher J Groves; Aimo Ruokonen; Marjo Riitta Jarvelin; Ewan Pearson; Laura Pascoe; Ele Ferrannini; Stefan R Bornstein; Heather M Stringham; Laura J Scott; Johanna Kuusisto; Peter Nilsson; Malin Neptin; Anette P Gjesing; Charlotta Pisinger; Torsten Lauritzen; Annelli Sandbaek; Mike Sampson; Ele Zeggini; Cecilia M Lindgren; Valgerdur Steinthorsdottir; Unnur Thorsteinsdottir; Torben Hansen; Peter Schwarz; Thomas Illig; Markku Laakso; Kari Stefansson; Andrew D Morris; Leif Groop; Oluf Pedersen; Michael Boehnke; Inês Barroso; Nicholas J Wareham; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling
Journal:  Hum Mol Genet       Date:  2009-11-18       Impact factor: 6.150
View more
  1 in total

1.  Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Milovan Jovanovic; Ivan Soldatovic; Najdana Gligorovic-Barhanovic; Jelena Kotur-Stevuljevic
Journal:  Arch Med Sci       Date:  2017-07-19       Impact factor: 3.318
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.